Open Terminal →

Analyses / HCA

HCA HCA Healthcare, Inc. As of Nov 19, 2026
$476.35

Large-cap hospital operator. Valuation looks moderate on earnings, but the stock fell 4.96% on the day and provider data leaves several gaps.

Setup: Pullback watch: mixed read after a sharp down day Confidence: medium Horizon: 1-3 months Risk: medium Category: Large Cap
🔒 Trade Plan — entry · target · stop
Entry Zone
$•••–•••
Target
$•••
Stop Loss
$•••
Risk / Reward
•.• : 1
Unlock the exact levels — free →

A free account reveals HCA's entry zone, price target & stop loss. Full 1-week to 1-year price forecasts are included with Pro.

The Thesis

▲ Bull Case

Earnings multiples look moderate: P/E 14.9x (price vs. annual profit), forward P/E 14.9x, EV/EBITDA 11.1x (enterprise value vs. cash earnings). EPS grew 13.9% and revenue 7.9%, with a 15.8% operating margin. Price is about 60% of the way up its 52-week range. If the day's drop proves sentiment-driven rather than fundamental, the multiple and margin profile could support a rebound toward the 1-month target band.

▼ Bear Case

Shares fell 4.96% in one session, and the payload gives no cause. Insider activity is net reducing: 64 sell transactions vs. 44 buys, with about 221.7M shares disposed vs. 184.6M acquired. Tangible book value is negative (-$44.78/share), and the current ratio is 0.97. Regulatory headlines, including a CMS proposed anti-fraud rule, add policy uncertainty for hospital operators.

Valuation

FAIRLY VALUED — score 60/100

Earnings and EBITDA multiples are moderate. Price-to-book is not usable because of a data conflict. Growth is positive but not high.

Technical Levels

Support · $472.90 (Day low) · $440.00 (Stop reference (analyst framework level)) · $353.99 (52-week low)

Resistance · $498.78 (Day high) · $501.19 (Prior close) · $556.52 (52-week high)

RSI: Not available in payload

Financial Health

Score 45/100. Short-term liquidity is thin and tangible equity is negative. Leverage and coverage ratios are missing, so the balance sheet cannot be fully assessed from this payload.

Catalysts

CMS proposed anti-fraud rule across Medicare, Medicaid/CHIP, and Marketplace (provider headline cites possible $90B savings over 10 years)Ongoing comment and rulemaking periodMedium to high: could affect hospital reimbursement and compliance costs
Next quarterly earnings report (date not in payload)Not in payloadHigh: would test EPS growth (13.9%) and revenue growth (7.9%) against the current multiple

Risk Flags

Day move of -4.96% has no explanation in the provider payload.
P/B of 97.3x conflicts with book value/share of $1.69. Treat P/B as unreliable.
Net insider selling: 64 sells vs. 44 buys; shares sold exceed shares bought.
Tangible book value is negative (-$44.78/share), so equity relies on intangibles.
ROE, ROA, ROIC, D/E, FCF/share, RSI, and interest coverage are null in the payload.
Current ratio 0.97 is below 1.0, a thin short-term liquidity cushion.

See HCA's full trade plan — free

Create a free account to unlock the exact entry, target, and stop — plus run live analysis on any of 5,000+ tickers. No card required.

Unlock HCA free →

Recent News

More Analyses

HCA FAQ

Is HCA a buy right now?

HCA Healthcare, Inc.'s current read is a Pullback watch: mixed read after a sharp down day setup with medium confidence over a 1-3 months horizon. Valuation: FAIRLY VALUED. See the full bull and bear case above, or run a live analysis for the exact entry, target and stop.

Is HCA overvalued?

FAIRLY VALUED (valuation score 60/100). Earnings and EBITDA multiples are moderate. Price-to-book is not usable because of a data conflict. Growth is positive but not high.

What are the risks of buying HCA?

Shares fell 4.96% in one session, and the payload gives no cause. Insider activity is net reducing: 64 sell transactions vs. 44 buys, with about 221.7M shares disposed vs. 184.6M acquired. Tangible book value is negative (-$44.78/share), and the current ratio is 0.97. Regulatory headlines, including a CMS proposed anti-fraud rule, add policy uncertainty for hospital operators.